The International Life Science & Health-Tech week in Israel
NurExone Biologic team will be participating the MIXiii Health-Tech.IL conference as a leading Life-Science publicly traded company! Read More…
November 7, 2022
NurExone Biologic team will be participating the MIXiii Health-Tech.IL conference as a leading Life-Science publicly traded company! Read More…
The healthcare sector is one of the industries that is rapidly recovering, and advances in drug research and development are yielding spectacular results. Canada is a global biotechnology leader, with the government assisting in the development of strong, competitive biomanufacturing and life sciences sector, making it a global investment opportunity
Prior to submission of a New Investigational Drug (IND) application, in September 2022, the Company submitted a request for an Initial Targeted Engagement for Regulatory Advice on CBER Products (INTERACT) meeting, which is an informal, non-binding meeting that is offered by the U.S. FDA to companies at an early stage